| 姓名 | 職稱 | 持有股份 | 代表法人 |
|---|---|---|---|
| Li,Pei-Lin | Chairman | 6.99% | |
| Li,Dian-Ying | Director | 48.86% | |
| Lin,Guo-Dong | Director | 0.01% | |
| Ding,Yong-Zhi | Director | 1.66% | |
| Mcfees Group Inc. | Director | 0.79% | |
| Zhang,Jia-Zheng | Independent Director | 0.00% | |
| Lin,Xiang-Hong | Independent Director | 0.00% | |
| Huang,Mu-Qi | Independent Director | 0.00% |
Change Company Name to XIN DA HEALTH INVESTMENT HOLDINGS CO., LTD.
2024/08/19
Change Company Name to XINDA HEALTH INVESTMENT HOLDINGS CO., LTD. (FORMER NAME: HUANRUI MEDICAL INVESTMENT HOLDINGS CO., LTD.)
2022/09/26
Change Capital to 2,500,000,000
2022/09/26
Change Company Name to XIN DA HEALTH INVESTMENT HOLDINGS CO., LTD.
2020/08/18
Change Person in Charge to Li,Pei-Lin
2018/09/06
Change Person in Charge to Guo,Shou-Ren
2017/07/14
Change Capital to 2,000,000,000
2015/01/08
| 項目 | 2024 | 2023 | 2022 |
|---|---|---|---|
| Operating income | 240,248 | 275,113 | 254,437 |
| Operating cost | 165,241 | 239,458 | 216,048 |
| Profit (loss) of initial recognition of biological asset and agricultural products | - | - | - |
| Profit (loss) on changes in fair value less costs to sell of biological asset for current period | - | - | - |
| Operating gross profit (loss) | 75,007 | 35,655 | 38,389 |
| Unrealized profit (loss) on sales of goods | - | - | - |
| Realized profit (loss) on sales of goods | - | - | - |
| Operating gross profit (loss), net | 75,007 | 35,655 | 38,389 |
| Operating expenses | 142,989 | 128,575 | 148,907 |
| Other gain (loss), net | - | - | - |
| Operating profit (loss) | -67,982 | -92,920 | -110,518 |
| Non-operating income and expenses | 21,651 | 195,778 | 40,148 |
| Net profit (loss) before tax | -46,331 | 102,858 | -70,370 |
| Income tax expense (benefits) | 2,163 | -33 | -1,211 |
| Net profit (loss) of ongoing business for the current period | -48,494 | 102,891 | -69,159 |
| Profit (loss) of closed units | - | - | - |
| Profit (loss) of non-jointly controlled equity before merger | - | - | - |
| Net profit (loss) for the current period | -48,494 | 102,891 | -69,159 |
| Other comprehensive profit (loss), net | 1,396 | 1,873 | -7,353 |
| Comprehensive net profit and loss of non-jointly controlled equity before merger | - | - | - |
| Total comprehensive profit and loss for the current period | -47,098 | 104,764 | -76,512 |
| Net profit (loss) attributable to owners of parent company | -41,279 | 103,609 | -66,885 |
| Net profit (loss) form equity attributable to former owner of business combination under common control | - | - | - |
| Net profit (loss) attributable to non-controlling interests | -7,215 | -718 | -2,274 |
| Comprehensive profit (loss) attributable to owners of parent company | -39,883 | 105,482 | -74,238 |
| Comprehensive profit (loss) form equity attributable to former owner of business combination under common control | - | - | - |
| Comprehensive profit (loss) attributable to non-controlling interests | -7,215 | -718 | -2,274 |
| Basic earnings per share (yuan) | -1 | 4 | -3 |
| 項目 | 2024 | 2023 | 2022 |
|---|---|---|---|
| Net cash inflow (outflow) from operating activities | -52,036 | -68,098 | -72,905 |
| Net cash inflows (outflows) from investing activities | 7,222 | 181,952 | -82,250 |
| Net cash inflow (outflow) from financing activities | -4,556 | -29,592 | 149,971 |
| Effect of Exchange Rate Changes on Cash and Cash Equivalents | 401 | 2,403 | -4,369 |
| Increase (decrease) in cash and cash equivalents in the current period | -48,969 | 86,665 | -9,553 |
| Beginning balance of cash and cash equivalents | 198,989 | 112,324 | 121,877 |
| Ending balance of cash and cash equivalents | 150,020 | 198,989 | 112,324 |
| 項目 | 2024 | 2023 | 2022 |
|---|---|---|---|
| Current asset | 307,981 | 399,920 | 316,274 |
| Non-current asset | 125,854 | 213,417 | 214,784 |
| Total asset | 433,835 | 613,337 | 531,058 |
| Current liability | 86,250 | 127,482 | 141,677 |
| Non-current liability | 29,993 | 81,762 | 173,961 |
| Total liability | 116,243 | 209,244 | 315,638 |
| share capital | 241,080 | 241,080 | 221,080 |
| Equity - secruity token | - | - | - |
| capital reserve | 40,000 | 40,000 | 94,500 |
| retained earning | -24,829 | 16,450 | -181,659 |
| Other equity | 4,603 | 3,207 | 1,334 |
| Treasury stock | - | - | - |
| Total equity attributable to owners of parent company | 260,854 | 300,737 | 135,255 |
| Equity attributable to former owner of business combination under common control | - | - | - |
| Equity attributable to non-controlling interest before business merger under common control | - | - | - |
| Non-controlling interests | 56,738 | 103,356 | 80,165 |
| Total Equity | 317,592 | 404,093 | 215,420 |
| Share capital awaiting retirement (unit: share) | 0 | 0 | 0 |
| Issued shares of advance equity (unit: shares) | 0 | 0 | 0 |
| Treasury shares of the parent company held by the parent company and its subsidiaries (unit: share) | 0 | 0 | 0 |
| Net asset value per share | 10 | 12 | 6 |
